ISRCTN72275160进行中（未招募）4 期
Proactive against reactive therapy for the prevention of lichen sclerosus exacerbation and progression of disease – a pragmatic, parallel group randomised controlled trial with embedded economic evaluation and process evaluation
ottingham Clinical Trials Unit0 个研究点目标入组 400 人开始时间: 2024年3月8日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. Clinical or biopsy confirmed diagnosis of vulval LS
- •2. Currently controlled disease (asymptomatic with minimal clinical evidence of active disease) at baseline
- •3. Age =5 years
- •4. Able to give consent/child assent plus parental consent
排除标准
- •1. Previous vulval intraepithelial neoplasia (VIN) or vulval squamous cell carcinoma (SCC)
- •2. Contraindications to topical steroids
- •3. Concomitant use of other topical anti-inflammatory vulval treatments
- •4. Using systemic immunosuppressants (for any indication)
- •5. Using systemic treatment for LS
- •6. Patients with surgical alteration of vulval skin as part of gender reaffirming surgery, or patients not born with a vulva
- •7. Pregnant and breastfeeding women
研究者
相似试验
招募中
不适用
Development of novel treatment strategy to prevent progression of arteriosclerosis in dialysis patientsend stage renal diseaseJPRN-UMIN000020384second department of internal medicine, Kansai Medical University Hirakata hospital100
尚未招募
1 期
A study on strategies for the prevention and treatment of metabolic syndrome in Chinese medicine and the preliminary construction of a predictive model for cardiovascular disease risk - a prospective cohort studyITMCTR2022000037Guang'anmen Hospital, China Academy of Chinese Medical Sciences
招募中
不适用
Prevention of malaria in pregnancy in IndiaCTRI/2012/08/002921Malaria in Pregnancy Consortium Liverpool3,100
进行中（未招募）
不适用
Preventive measures and therapies for back painslow back pain, neck pain and postureM54.5M54.2G11.427.695RBR-78bq5xMaria das Graças Rodrigues de Araújo
招募中
不适用
ovel strategies of preventions and therapies for esophageal cancer using bioactive molecules derived from oral flora or probioticsesophageal squamous cell carcinoma, esophageal adenocarcinoma, esophageal squamous dysplasia, Barrett's esophagusJPRN-UMIN000025105Asahikawa Medical University60